Back

Recombinant tissue plasminogen activator as a modifier of treatment effect in prosthetic valve thrombosis: systematic review and meta-regression

10 May 2026 (11:07 - 11:18)
Organised by: Logo
Congress Presentation Part of: Valvular innovation frontline: from imaging to intervention Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emidio Mata

Unidade Local de Saude do Alto Ave - Hospital Senhora da Oliveira - Guimaraes, Creixomil (Portugal)

3 More presentations in this session

Presentation thumbnail
Cardiac index integrates cardiac and extracardiac dysfunction in tricuspid regurgitation across the heart failure spectrum
Assistant Professor N. Pugliese (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
CT-derived extracellular volume provides added prognostic value over global longitudinal strain in severe aortic stenosis
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Down-regulation of PTEN via miR-19b is associated with fibrosis in aortic stenosis in females
Doctor E. Jover (Pamplona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular innovation frontline: from imaging to intervention
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 11:07 CET
You may be interested in
thumbnail
Congress Presentation
Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis
thumbnail
Congress Presentation
Urgent surgery compared to fibrinolytic therapy for the treatment of left-sided mechanical valve thrombosis (SAFE-PVT): a randomized controlled trial
thumbnail
Congress Presentation
Unblocking the heart

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources